Wei-Yu Meng

522 total citations
6 papers, 312 citations indexed

About

Wei-Yu Meng is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei-Yu Meng has authored 6 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei-Yu Meng's work include Autophagy in Disease and Therapy (2 papers), Andrographolide Research and Applications (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). Wei-Yu Meng is often cited by papers focused on Autophagy in Disease and Therapy (2 papers), Andrographolide Research and Applications (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). Wei-Yu Meng collaborates with scholars based in China, Macao and Israel. Wei-Yu Meng's co-authors include Elaine Lai‐Han Leung, Qibiao Wu, Hudan Pan, Xing‐Xing Fan, Peiyu Yan, Runze Li, Xiaojun Yao, Liang Liu, Chun Xie and Xuan‐Run Wang and has published in prestigious journals such as Medicine, Pharmacological Research and BMC Cancer.

In The Last Decade

Wei-Yu Meng

6 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei-Yu Meng China 5 125 66 63 48 45 6 312
Yijun Tang China 11 241 1.9× 71 1.1× 126 2.0× 138 2.9× 45 1.0× 26 466
Jiming Zhou United States 11 197 1.6× 27 0.4× 65 1.0× 33 0.7× 29 0.6× 21 383
Hisashi Johno Japan 13 137 1.1× 35 0.5× 20 0.3× 31 0.6× 22 0.5× 21 345
Hongyu Jing China 14 220 1.8× 47 0.7× 72 1.1× 162 3.4× 63 1.4× 15 471
Danqing Hu China 11 266 2.1× 79 1.2× 37 0.6× 175 3.6× 123 2.7× 26 538
Tingyuan Lang China 13 227 1.8× 18 0.3× 62 1.0× 94 2.0× 17 0.4× 25 429
Ming-Bai Hu China 14 177 1.4× 33 0.5× 45 0.7× 102 2.1× 28 0.6× 19 435
Evangelos Hytopoulos United States 10 212 1.7× 39 0.6× 15 0.2× 28 0.6× 13 0.3× 21 452

Countries citing papers authored by Wei-Yu Meng

Since Specialization
Citations

This map shows the geographic impact of Wei-Yu Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Yu Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Yu Meng more than expected).

Fields of papers citing papers by Wei-Yu Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Yu Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Yu Meng. The network helps show where Wei-Yu Meng may publish in the future.

Co-authorship network of co-authors of Wei-Yu Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Yu Meng. A scholar is included among the top collaborators of Wei-Yu Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Yu Meng. Wei-Yu Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Wang, Xuan‐Run, Zebo Jiang, Cong Xu, et al.. (2022). Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response. Pharmacological Research. 179. 106198–106198. 54 indexed citations
2.
Li, Runze, Xuan‐Run Wang, Jian Wang, et al.. (2022). The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance. Frontiers in Oncology. 12. 941643–941643. 56 indexed citations
3.
Meng, Wei-Yu, Imran Khan, Xing‐Xing Fan, et al.. (2022). Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor. Medicine. 101(41). e31027–e31027. 1 indexed citations
4.
Li, Runze, Cong Xu, Xing‐Xing Fan, et al.. (2021). Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa. Phytomedicine. 95. 153786–153786. 41 indexed citations
5.
Chen, Huihui, Wei-Yu Meng, Runze Li, et al.. (2021). Potential prognostic factors in progression-free survival for patients with cervical cancer. BMC Cancer. 21(1). 531–531. 13 indexed citations
6.
Xie, Ying, Wei-Yu Meng, Runze Li, et al.. (2020). Early lung cancer diagnostic biomarker discovery by machine learning methods. Translational Oncology. 14(1). 100907–100907. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yijun Tang Breakdown of academic impact, for papers by Jiming Zhou Breakdown of academic impact, for papers by Hisashi Johno Breakdown of academic impact, for papers by Hongyu Jing Breakdown of academic impact, for papers by Danqing Hu Breakdown of academic impact, for papers by Tingyuan Lang Breakdown of academic impact, for papers by Ming-Bai Hu Breakdown of academic impact, for papers by Evangelos Hytopoulos
Rankless by CCL
2026